SCHEMBL20945457

SCHEMBL20945457

CCn1c2ccccc2c2cc(Nc3nc(N)ncc3CCCn3ccnc3)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ CREBBP Q92793 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ RAC1 P63000 1/20 0.41
▸ MEN1 O00255 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ KDM4E B2RXH2 4/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ HPGD P15428 1/20 0.40
▸ HBB P68871 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ NPY5R Q15761 2/20 0.40
▸ TERT O14746 1/20 0.40
▸ LMNA P02545 3/20 0.39
▸ KDM1A O60341 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29920372 0.74 RAC1 (0.71) MAPTMAPK1HTTPOLBTSHR
SCHEMBL20966317 0.74 RAC1 (0.71) MAPTMAPK1HTTPOLBTSHR
SCHEMBL20945458 0.73 HSD17B10 (0.51) MAPTL3MBTL1MEN1KMT2AKDM4E
SCHEMBL20945456 0.73 MAPT (0.48) MAPTMAPK1HTTPOLBTSHR
SCHEMBL5741119 0.72 MAPT (0.56) MAPTMAPK1HTTPOLBTSHR
SCHEMBL20945454 0.72 DRD3 (0.43) MAPTMAPK1HTTPOLBTSHR
SCHEMBL30523145 0.69 KMT2A (0.60) MAPTMAPK1POLBL3MBTL1MEN1
SCHEMBL29059420 0.69 KMT2A (0.60) MAPTMAPK1POLBL3MBTL1MEN1
SCHEMBL29059521 0.69 KMT2A (0.56) MAPTMAPK1POLBL3MBTL1MEN1
SCHEMBL30523162 0.69 KMT2A (0.56) MAPTMAPK1POLBL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446299-B2 Carbazole EHop-016 derivatives as anticancer and anti-migratory agents UNIVERSITY OF PUERTO RICO (US) 2022-09-20 — — US disclosed
US-20200352941-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS UNIV PUERTO RICO (US) 2020-11-12 — — US disclosed
US-10729689-B2 Carbazole EHop-016 derivatives as anti-cancer and anti-migratory agents UNIVERSITY OF PUERTO RICO (US) 2020-08-04 — — US disclosed
US-20190125746-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS UNIVERSITY OF PUERTO RICO (PR) 2019-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200352941-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS CDC42, ARHGEF2, ARHGDIB MAPT 4054/4885MAPK1 395/4885HTT 2339/4885
US-11446299-B2 Carbazole EHop-016 derivatives as anticancer and anti-migratory agents CDC42, ARHGEF2, HRAS MAPT 3790/4885MAPK1 351/4885HTT 1746/4885
US-20190125746-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS CDC42, ARHGEF2, HRAS MAPT 3896/4885MAPK1 482/4885HTT 1686/4885
US-10729689-B2 Carbazole EHop-016 derivatives as anti-cancer and anti-migratory agents CDC42, ARHGEF2, GDI2 MAPT 3908/4885MAPK1 393/4885HTT 1971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback